In smoker COPD patients, steroid treatment did not suppress these pathways, while a combination of steroid and STING inhibitor significantly reduced the expression of STING/IFN-β signaling and lowered the expression of remodeling markers. This evidence concerns the gene STING1 and chronic obstructive pulmonary disease.